ストックスクリーナーアプリを入手
2.1507
2.93%
-0.0693
前日終値:
$2.22
開ける：
$2.24
24時間の取引高:
2.50M
Relative Volume:
1.27
時価総額：
$169.93M
収益：
-
当期純損益:
$-117.23M
株価収益率:
-0.9644
EPS:
-2.23
ネットキャッシュフロー:
$-95.25M
1週間 パフォーマンス:
+6.68%
1か月 パフォーマンス:
+12.24%
6か月 パフォーマンス:
-48.44%
1年 パフォーマンス:
+19.06%
1日の値動き範囲:
$2.08
$2.24
1週間の範囲:
$1.91
$2.51
52週間の値動き範囲:
$1.61
$7.01
Tenaya Therapeutics Inc Stock (TNYA) Company Profile
名前
Tenaya Therapeutics Inc
セクター
電話
415-865-2066
住所
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
TNYA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| TNYA | 2.1507 | 169.93M | 0 | -117.23M | -95.25M | -2.23 |
| VRTX | 450.26 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 746.04 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 591.88 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 245.32 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 107.56 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-06-15 | 開始されました | H.C. Wainwright | Buy |
Tenaya Therapeutics Inc (TNYA) 最新ニュース
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - The Manila Times
Tenaya Therapeutics Issues Stock Options to New Employees at $1.97 Per Share | TNYA Stock News - StockTitan
Tenaya Therapeutics SVP sells $4,786 in stock - Investing.com
RA Capital Management's Strategic Acquisition in Tenaya Therapeu - GuruFocus.com
William Blair Brokers Increase Earnings Estimates for TNYA - MarketBeat
Research Analysts Offer Predictions for TNYA FY2024 Earnings - MarketBeat
Leerink Partnrs Issues Optimistic Estimate for TNYA Earnings - MarketBeat
Tenaya Therapeutics, Inc.'s (NASDAQ:TNYA) large institutional owners must be happy as stock continues to impress, up 42% over the past week - Simply Wall St
Tenaya Therapeutics (NASDAQ:TNYA) Price Target Lowered to $18.00 at Chardan Capital - MarketBeat
Latham Group, Inc. to Participate in the Baird 2024 Global Industrial Conference - The Manila Times
Tenaya Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
abrdn plc Invests $1.06 Million in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - MarketBeat
BeyondSpring (BYSI) Stock Drops Amid Biotech Sector Volatility - GuruFocus.com
Beam Therapeutics (BEAM) Stock Surges with Strong Trading Volume - GuruFocus.com
Morgan Stanley Predicts Up to 670% Jump for These 2 ‘Strong Buy’ Stocks - Yahoo Finance
Here's Why We're Watching Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Situation - Yahoo Finance
Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Piper Sandler raises confidence in Tenaya Therapeutics stock ahead of December data, reiterates Overweight rating - Investing.com Australia
Tenaya shares retain stock target, buy rating on safety milestone - Investing.com
Tenaya shares hold buy rating, positive outlook on trial progress - Investing.com
Tenaya Therapeutics' (TNYA) "Buy" Rating Reiterated at Canaccord Genuity Group - MarketBeat
Leerink sees Tenaya's trial update as positive, maintains price target By Investing.com - Investing.com UK
Tenaya stock undervalued despite strong Ph1 safety update, says Canaccord - Investing.com
Tenaya (TNYA) Experiences Notable Stock Increase Following Key Update - Stocks Telegraph
Tenaya shares hold buy rating, positive outlook on trial progress By Investing.com - Investing.com UK
Tenaya advances gene therapy trial for heart condition - Investing.com
Tenaya Therapeutics Announces Updates on TN-201 Gene Therapy Program for MYBPC3-associated HCM - GlobeNewswire
SVP, Accounting and Fin. Ops. Saito Chihiro sold 2,363 shares of Tenaya Therapeutics Inc [TNYA] - Knox Daily
Tenaya Therapeutics stock hits 52-week low at $1.63 By Investing.com - Investing.com Canada
Technical analysis of Tenaya Therapeutics Inc (TNYA) stock chart patterns - US Post News
A Closer Look at Tenaya Therapeutics Inc (TNYA) Stock Gains - The InvestChronicle
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Average Rating of "Buy" by Brokerages - MarketBeat
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Average Recommendation of “Buy” by Brokerages - Defense World
Hypertrophic Cardiomyopathy Market Expected to Experience Major Growth by 2034, According to DelveInsight | Edgewise Therapeutics, Inc., Lexicon Pharmaceuticals, Shandong Suncadia Medicine, Ji Xing - Barchart
Charting the Course: Tenaya Therapeutics Inc’s TNYA Stock Prospects - The InvestChronicle
Tenaya Therapeutics Inc (TNYA) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News
Daily Progress: Tenaya Therapeutics Inc (TNYA) Drop -3.11, Closing at 1.87 - The Dwinnex
Tenaya Therapeutics Inc [TNYA] Insider Activity: An Update for Investors - Knox Daily
Canaccord keeps buy rating, price target on Tenaya shares - Investing.com
Tenaya Therapeutics' SWOT analysis: gene therapy stock poised for pivotal catalysts By Investing.com - Investing.com South Africa
Tenaya Therapeutics' SWOT analysis: gene therapy stock poised for pivotal catalysts - Investing.com India
Myocardial Infarction Global Market Report 2024 Size and Forecast - WhaTech
Septerna Marks Transition to a Clinical-Stage Company with Appointments of Industry Veterans in Key Drug Development Roles - Business Wire
A closer look at Tenaya Therapeutics Inc (TNYA)’s stock price trends - US Post News
Owning 43% shares,institutional owners seem interested in Tenaya Therapeutics, Inc. (NASDAQ:TNYA), - Yahoo Finance
Rocket Pharmaceuticals Maxes Out Recruitment in Pivotal Trial for Danon Disease Gene Therapy RP-A501 - CGTLive™
Recent Insider Activity Could Benefit Tenaya Therapeutics Inc (TNYA) - Knox Daily
Tenon Medical Inc (TNON) expanding its growth trajectory ahead - SETE News
Tenet Healthcare Corp. (THC) Stock: A Year of Market Fluctuations - The InvestChronicle
Daily Market Movement: Tenon Medical Inc (TNON) Sees a -18.94 Decrease, Closing at 6.25 - The Dwinnex
Tenaya Therapeutics Inc (TNYA) 財務データ
収益
当期純利益
現金流量
EPS
1.80%
0.42%
大文字化:
|
ボリューム (24 時間):